Human cytochrome P450s involved in the metabolism of 9-cis- and 13-cis-retinoic acids

Biochemical Pharmacology

Volumn 63, Issue 5, 2002, Pages 933-943

  Marill, Julie ^a   Capron, Claude C ^a   Idres, Nadia ^a   Chabot, Guy G ^a  

^a INSERM   (France)

Author keywords

13 Cis retinoic acid; 9 Cis retinoic acid; CYP; CYP2C8; CYP2C9; CYP3A4; CYP3A7; Cytochrome P450s; Metabolism; Retinoic acid 4 oxidation; Retinoids

Indexed keywords

4 HYDROXY 13 RETINOIC ACID; 4 OXOISOTRETINOIN; ALITRETINOIN; CYTOCHROME P450; CYTOCHROME P450 1B1; CYTOCHROME P450 2A6; CYTOCHROME P450 2B6; CYTOCHROME P450 2C19; CYTOCHROME P450 2C8; CYTOCHROME P450 2C9; CYTOCHROME P450 3A4; CYTOCHROME P450 3A5; CYTOCHROME P450 3A7; CYTOCHROME P450 4A11; CYTOCHROME P450 INHIBITOR; ISOTRETINOIN; KETOCONAZOLE; QUERCETIN; RETINOIC ACID DERIVATIVE; SULFAPHENAZOLE; TROLEANDOMYCIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG METABOLISM; ENZYME ACTIVITY; FETUS; HUMAN; HUMAN TISSUE; LIVER MICROSOME; LYMPHOBLAST; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEREOISOMERISM;

CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INHIBITORS; HUMANS; HYDROXYLATION; ISOTRETINOIN; KINETICS; MICROSOMES, LIVER; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0036496591     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(01)00925-X     Document Type: Article

References (45)

1. Cellular biology and biochemistry of the retinoids
2. Retinoids and human cancer
3. Retinoids in chemoprevention and differentiation therapy
4. Biosynthesis of all-trans-retinoic acid from all-trans-retinol: Catalysis of all-trans-retinol oxidation by human P-450 cytochromes
5. Human cytochrome P-450 metabolism of retinals to retinoic acids
6. The RXR heterodimers and orphan receptors
7. 9-Cis retinoic acid is a high affinity ligand for the retinoid X receptor
8. Retinoylation of HL-60 proteins: Comparison to labeling by palmitic and myristic acids
9. Retinoids and their receptors in differentiation, embryogenesis, and neoplasia
10. Retinoid metabolism and all-trans retinoic acid-induced growth inhibition in head and neck squamous cell carcinoma cell lines
11. Effects of retinoic acid on cell differentiation and reversion toward normal in human endometrial adenocarcinoma (RL95-2) cells
12. Retinoic acid metabolites exhibit biological activity in human keratinocytes, mouse melanoma cells and hairless mouse skin in vivo
13. All-trans-retinoic acid metabolites significantly inhibit the proliferation of MCF-7 human breast cancer cells in vitro
14. Effects of retinoic acid metabolites on proliferation and differentiation of the clonal rhabdomyosarcoma cell line BA-HAN-1C
15. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites
16. Retinoic acid metabolism and inhibition of cell proliferation: An unexpected liaison
17. Autoinduction of retinoic acid metabolism to polar derivatives with decreased biological activity in retinoic acid-sensitive, but not in retinoic acid-resistant human breast cancer cells
18. Metabolism of retinol and retinoic acid by human liver cytochrome P450IIC8
19. Participation of CYP2C8 in retinoic acid 4-hydroxylation in human hepatic microsomes
20. CYP26, a novel mammalian cytochrome P450, is induced by retinoic acid and defines a new family
21. cDNA cloning of human retinoic acid-metabolizing enzyme (hP450RAI) identifies a novel family of cytochromes P450
22. Catalysis of the 4-hydroxylation of retinoic acids by CYP3a7 in human fetal hepatic tissues
23. Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites
24. Identification of human cytochrome P450 isoforms that contribute to all-trans-retinoic acid 4-hydroxylation
25. Phase I study and pharmacokinetics of weekly high-dose 13-cis-retinoic acid
26. Clinical pharmacology of all-trans-retinoic acid
27. 9-Cis retinoic acid induces complete remission but does not reverse clinically acquired retinoid resistance in acute promyelocytic leukemia
28. Pharmacokinetic studies of 13-cis-retinoic acid in pediatric patients with neuroblastoma following bone marrow transplantation
29. Phase I clinical trial of alitretinoin and tamoxifen in breast cancer patients: Toxicity, pharmacokinetic, and biomarker evaluations
30. Cytochrome P-450-mediated metabolism of the individual enantiomers of the antidepressant agent reboxetine in human liver microsomes
31. Cytochrome P450 inhibitors: Evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes
32. Involvement of cytochromes P-450 2E1 and 3A4 in the 5-hydroxylation of salicylate in humans
33. Heterologous expression and kinetic characterization of human cytochromes P-450: Validation of a pharmaceutical tool for drug metabolism research
34. Oxidation of troglitazone to a quinone-type metabolite catalyzed by cytochrome P-450 2C8 and P-450 3A4 in human liver microsomes
35. Retinoid metabolism in the skin
36. Human cytochrome P4502B6: Interindividual hepatic expression, substrate specificity, and role in procarcinogen activation
37. A highly sensitive tool for the assay of cytochrome P450 enzyme activity in rat, dog and man: Direct fluorescence monitoring of the deethylation of 7-ethoxy-4-trifluoromethylcoumarin
38. Biochemistry and molecular biology of the human CYP2C subfamily
39. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians
40. Cytochrome P4502C9: An enzyme of major importance in human drug metabolism
41. High frequency of mutations related to impaired CYP2C9 metabolism in a Caucasian population
42. Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver
43. Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver
44. Retinoic acid isomers applied to human skin in vivo each induce a 4-hydroxylase that inactivates only trans retinoic acid
45. All-trans-retinoic acid 4-hydroxylation in human liver microsomes: In vitro modulation by therapeutic retinoids